COMPASS THERAPEUTICS INC's ticker is CMPX and the CUSIP is 20454B104. A total of 35 filers reported holding COMPASS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,088,156 | -33.6% | 6,660,638 | +7.1% | 0.01% | -25.0% |
| Q2 2023 | $19,713,413 | +0.5% | 6,218,741 | +3.6% | 0.01% | -7.7% |
| Q1 2023 | $19,616,292 | -34.2% | 6,004,473 | +1.1% | 0.01% | -38.1% |
| Q4 2022 | $29,802,571 | +269.0% | 5,939,290 | -15.7% | 0.02% | +250.0% |
| Q3 2022 | $8,076,068 | -8.3% | 7,045,960 | +110.5% | 0.01% | 0.0% |
| Q2 2022 | $8,803,000 | +103.4% | 3,347,171 | +4.8% | 0.01% | +200.0% |
| Q1 2022 | $4,327,000 | -7.9% | 3,193,294 | +116.8% | 0.00% | 0.0% |
| Q4 2021 | $4,698,000 | – | 1,472,611 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 3,500,000 | $11,165,000 | 7.28% |
| Foresite Capital Management V, LLC | 4,400,000 | $13,948,000 | 3.43% |
| CHI Advisors LLC | 3,023,692 | $9,585,000 | 3.18% |
| Foresite Capital Opportunity Management V, LLC | 1,100,000 | $3,487,000 | 2.34% |
| Monashee Investment Management LLC | 2,000,000 | $6,340,000 | 1.57% |
| Orbimed Advisors | 21,642,975 | $68,608,000 | 0.88% |
| Rock Springs Capital Management LP | 5,328,088 | $16,890,000 | 0.39% |
| Vivo Capital, LLC | 2,000,000 | $6,340,000 | 0.38% |
| SPHERA FUNDS MANAGEMENT LTD. | 700,000 | $2,219,000 | 0.24% |
| DAFNA Capital Management LLC | 196,091 | $622,000 | 0.16% |